Literature DB >> 18474593

Plasmin potentiates synaptic N-methyl-D-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1.

Guido Mannaioni1, Anna G Orr, Cecily E Hamill, Hongjie Yuan, Katherine H Pedone, Kelly L McCoy, Rolando Berlinguer Palmini, Candice E Junge, C Justin Lee, Manuel Yepes, John R Hepler, Stephen F Traynelis.   

Abstract

Protease-activated receptor-1 (PAR1) is activated by a number of serine proteases, including plasmin. Both PAR1 and plasminogen, the precursor of plasmin, are expressed in the central nervous system. In this study we examined the effects of plasmin in astrocyte and neuronal cultures as well as in hippocampal slices. We find that plasmin evokes an increase in both phosphoinositide hydrolysis (EC(50) 64 nm) and Fura-2/AM fluorescence (195 +/- 6.7% above base line, EC(50) 65 nm) in cortical cultured murine astrocytes. Plasmin also activates extracellular signal-regulated kinase (ERK1/2) within cultured astrocytes. The plasmin-induced rise in intracellular Ca(2+) concentration ([Ca(2+)](i)) and the increase in phospho-ERK1/2 levels were diminished in PAR1(-/-) astrocytes and were blocked by 1 microm BMS-200261, a selective PAR1 antagonist. However, plasmin had no detectable effect on ERK1/2 or [Ca(2+)](i) signaling in primary cultured hippocampal neurons or in CA1 pyramidal cells in hippocampal slices. Plasmin (100-200 nm) application potentiated the N-methyl-D-aspartate (NMDA) receptor-dependent component of miniature excitatory postsynaptic currents recorded from CA1 pyramidal neurons but had no effect on alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate- or gamma-aminobutyric acid receptor-mediated synaptic currents. Plasmin also increased NMDA-induced whole cell receptor currents recorded from CA1 pyramidal cells (2.5 +/- 0.3-fold potentiation over control). This effect was blocked by BMS-200261 (1 microm; 1.02 +/- 0.09-fold potentiation over control). These data suggest that plasmin may serve as an endogenous PAR1 activator that can increase [Ca(2+)](i) in astrocytes and potentiate NMDA receptor synaptic currents in CA1 pyramidal neurons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474593      PMCID: PMC2459301          DOI: 10.1074/jbc.M803015200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes.

Authors:  Scott D Sorensen; Olivier Nicole; Richard D Peavy; Lisa M Montoya; C Justin Lee; T J Murphy; Stephen F Traynelis; John R Hepler
Journal:  Mol Pharmacol       Date:  2003-11       Impact factor: 4.436

Review 2.  Expression mechanisms underlying long-term potentiation: a postsynaptic view.

Authors:  Roger A Nicoll
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

3.  Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity.

Authors:  Petti T Pang; Henry K Teng; Eugene Zaitsev; Newton T Woo; Kazuko Sakata; Shushuang Zhen; Kenneth K Teng; Wing-Ho Yung; Barbara L Hempstead; Bai Lu
Journal:  Science       Date:  2004-10-15       Impact factor: 47.728

4.  Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors.

Authors:  Tommaso Fellin; Olivier Pascual; Sara Gobbo; Tullio Pozzan; Philip G Haydon; Giorgio Carmignoto
Journal:  Neuron       Date:  2004-09-02       Impact factor: 17.173

5.  The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia.

Authors:  Candice E Junge; Taku Sugawara; Guido Mannaioni; Sudar Alagarsamy; P Jeffrey Conn; Daniel J Brat; Pak H Chan; Stephen F Traynelis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-14       Impact factor: 11.205

6.  Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4.

Authors:  Todd M Quinton; Soochong Kim; Claudia K Derian; Jianguo Jin; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2004-02-18       Impact factor: 5.157

7.  Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes.

Authors:  Candice E Junge; C Justin Lee; Katherine B Hubbard; Zhoabin Zhang; Jeffrey J Olson; John R Hepler; Daniel J Brat; Stephen F Traynelis
Journal:  Exp Neurol       Date:  2004-07       Impact factor: 5.330

8.  Intracellular astrocyte calcium waves in situ increase the frequency of spontaneous AMPA receptor currents in CA1 pyramidal neurons.

Authors:  Todd A Fiacco; Ken D McCarthy
Journal:  J Neurosci       Date:  2004-01-21       Impact factor: 6.167

9.  Learning and memory deficits in mice lacking protease activated receptor-1.

Authors:  Antoine G Almonte; Cecily E Hamill; Jasmeer P Chhatwal; Thomas S Wingo; Jeremy A Barber; Polina N Lyuboslavsky; J David Sweatt; Kerry J Ressler; David A White; Stephen F Traynelis
Journal:  Neurobiol Learn Mem       Date:  2007-06-01       Impact factor: 2.877

10.  The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release.

Authors:  Taku Nagai; Kiyofumi Yamada; Masako Yoshimura; Kazuhiro Ishikawa; Yoshiaki Miyamoto; Kazuki Hashimoto; Yukihiro Noda; Atsumi Nitta; Toshitaka Nabeshima
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

View more
  38 in total

Review 1.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

2.  Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.

Authors:  Kelly L McCoy; Stefka Gyoneva; Christopher P Vellano; Alan V Smrcka; Stephen F Traynelis; John R Hepler
Journal:  Cell Signal       Date:  2012-01-28       Impact factor: 4.315

3.  In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.

Authors:  Emilia S Olson; Michael A Whitney; Beth Friedman; Todd A Aguilera; Jessica L Crisp; Fred M Baik; Tao Jiang; Stephen M Baird; Sotirios Tsimikas; Roger Y Tsien; Quyen T Nguyen
Journal:  Integr Biol (Camb)       Date:  2012-04-26       Impact factor: 2.192

Review 4.  Proteases display biased agonism at protease-activated receptors: location matters!

Authors:  Angela Russo; Unice J K Soh; JoAnn Trejo
Journal:  Mol Interv       Date:  2009-04

Review 5.  Roles of proteolysis in regulation of GPCR function.

Authors:  G S Cottrell
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  PAR1-activated astrocytes in the nucleus of the solitary tract stimulate adjacent neurons via NMDA receptors.

Authors:  Katie M Vance; Richard C Rogers; Gerlinda E Hermann
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

7.  Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity.

Authors:  J Parcq; T Bertrand; A Montagne; A F Baron; R Macrez; J M Billard; A Briens; Y Hommet; J Wu; M Yepes; H R Lijnen; P Dutar; E Anglés-Cano; D Vivien
Journal:  Cell Death Differ       Date:  2012-06-29       Impact factor: 15.828

8.  PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.

Authors:  Kelly L McCoy; Stephen F Traynelis; John R Hepler
Journal:  Mol Pharmacol       Date:  2010-03-09       Impact factor: 4.436

9.  Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis.

Authors:  Troy A McEachron; Rafal Pawlinski; Kristy L Richards; Frank C Church; Nigel Mackman
Journal:  Blood       Date:  2010-08-24       Impact factor: 22.113

10.  Tissue-type plasminogen activator regulates p35-mediated Cdk5 activation in the postsynaptic terminal.

Authors:  Ariel Diaz; Valerie Jeanneret; Paola Merino; Patrick McCann; Manuel Yepes
Journal:  J Cell Sci       Date:  2019-02-28       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.